Using animal material for medical device testing brings a range of problems such as variability, biohazards, and associated logistic and economic challenges. A physiochemical model that accurately replicates target biological material and allows standardized medical device testing was designed and implemented for Becton, Dickinson and Company (BD) - one of the largest medical technology companies worldwide. As per the NDA signed with BD, the material names as well as the numerical values associated are only representative values.